The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1997-06-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.94.13.6910PMID 9192665PMCID PMC21258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pillars article: A protein tyrosine kinase in the interferon α/β signaling pathway. Cell. 1992. 70: 313-322.

  2011cited by this paper
• Signaling by IL‐2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency

  1996cited by this paper
• Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells.

  1996cited by this paper
• A membrane-proximal region of the interleukin-2 receptor gamma c chain sufficient for Jak kinase activation and induction of proliferation in T cells

  1996cited by this paper
• Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

  1996cited by this paper
• Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.

  1996cited by this paper
• Kinase‐negative mutants of JAK1 can sustain interferon‐gamma‐inducible gene expression but not an antiviral state.

  1996cited by this paper
• In vitro recombination and mutagenesis by overlap extension PCR.

  1996cited by this paper
• Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.

  1995cited by this paper
• Identification and purification of human Stat proteins activated in response to interleukin-2.

  1995cited by this paper
• Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)

  1995cited by this paper
• Signaling through the hematopoietic cytokine receptors.

  1995cited by this paper
• Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development

  1995cited by this paper
• Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction.

  1995cited by this paper
• Regions of the JAK2 Tyrosine Kinase Required for Coupling to the Growth Hormone Receptor (*)

  1995cited by this paper
• A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin‐6.

  1995cited by this paper
• Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.

  1995cited by this paper
• Jak-STAT signaling induced by the v-abl oncogene.

  1995cited by this paper
• Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

  1995cited by this paper
• The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.

  1995cited by this paper
• Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

  1995cited by this paper
• The Conserved Box 1 Motif of Cytokine Receptors Is Required for Association with JAK Kinases (*)

  1995cited by this paper
• Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.

  1995cited by this paper
• Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and non-tyrosine residues of the gamma c chain.

  1995cited by this paper
• The Amino-terminal Portion of the JAK2 Protein Kinase Is Necessary For Binding and Phosphorylation of the Granulocyte-Macrophage Colony-stimulating Factor Receptor β Chain (*)

  1995cited by this paper
• Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3

  1995cited by this paper
• Defective Lymphoid Development in Mice Lacking Jak3

  1995cited by this paper
• Cytokine signaling through nonreceptor protein tyrosine kinases.

  1995cited by this paper
• Growth Signal Transduction by the Human Interleukin-2 Receptor Requires Cytoplasmic Tyrosines of the β Chain and Non-tyrosine Residues of the γc Chain (*)

  1995cited by this paper
• Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

  1994cited by this paper
• Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.

  1994cited by this paper
• Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2

  1994cited by this paper
• Signal transduction mediated by the reconstituted IL-2 receptor. Evidence for a cell type-specific function of IL-2 receptor beta-chain.

  1994cited by this paper
• Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15.

  1994cited by this paper
• JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region

  1994cited by this paper
• Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.

  1994cited by this paper
• Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.

  1994cited by this paper
• Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes.

  1994cited by this paper
• Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells

  1994cited by this paper
• Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID).

  1994cited by this paper
• JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.

  1994cited by this paper
• Lymphocyte responses and cytokines.

  1994cited by this paper
• The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.

  1993cited by this paper
• The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction

  1993cited by this paper
• Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway.

  1993cited by this paper
• JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.

  1993cited by this paper
• Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-& gamma; signal transduction pathway

  1993cited by this paper
• JAK2, a third member of the JAK family of protein tyrosine kinases.

  1992cited by this paper
• A protein tyrosine kinase in the interferon alpha/beta signaling pathway.

  1992cited by this paper

• Activity Regulation and Conformation Response of Janus Kinase 3 Mediated by Phosphorylation: Exploration from Correlation Network Analysis and Markov Model

  2025cites this paper
• JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions

  2023cites this paper
• Design, Synthesis and Bioactivity Study of Marine Alkaloid Neobacillamide—A Derivatives

  2023cites this paper
• Essential role of an acidic endosomal environment in JAK3-mediated signal transduction

  2023cites this paper
• Transcriptome Analysis Reveals Key miRNA–mRNA Pathways in Ovarian Tissues of Yunshang Black Goats With Different Kidding Numbers

  2022cites this paper
• Multidimensional Immune Profiling of Cutaneous Lupus Erythematosus In Vivo Stratified by Patient Response to Antimalarials

  2022cites this paper
• Case Report: Mutations in JAK3 causing severe combined immunodeficiency complicated by disseminated Bacille Calmette–Guérin disease and Pneumocystis pneumonia

  2022cites this paper
• Role of intracellular signaling pathways and their inhibitors in the treatment of inflammation

  2021cites this paper
• A primer on cytokines.

  2021cites this paper
• Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies

  2021influential citation
• Discovery of diaminopyrimidine-carboxamide derivatives as JAK3 inhibitors.

  2020cites this paper
• Common and different roles of IL-4 and IL-13 in skin allergy and clinical implications.

  2019cites this paper
• Essential Kinases and Transcriptional Regulators and Their Roles in Autoimmunity

  2019cites this paper
• The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects

  2018cites this paper
• The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK–Receptor Interactions

  2017cites this paper
• The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin

  2017cites this paper
• A molecular dissection of neuroinflammation in ovine Batten disease

  2016cites this paper
• Jak-STAT Signaling Pathways

  2016cites this paper
• Why do children with severe combined immunodeficiency get warts? The role of the common γ-chain in skin immunity

  2016influential citation
• Differential regulation of Janus kinase 3 (JAK3) in bovine preovulatory follicles and identification of JAK3 interacting proteins in granulosa cells

  2016cites this paper
• The role of thrombopoietin signalling in JAK2V617F-positive myeloproliferative neoplasms

  2015cites this paper
• In Vivo Role of JAK2 in the Pathogenesis of Obesity and the Metabolic Syndrome

  2015cites this paper
• Efeito de SMADs e de microRNAs na expressão gênica de TGF-β1 e seu papel na angiogênese em pacientes com mielofibrose e trombocitemia essencial

  2015cites this paper
• Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases.

  2015cites this paper
• JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications

  2015cites this paper
• Integrating non-coding RNAs in JAK-STAT regulatory networks

  2014cites this paper
• Structural basis of IFN receptor recognition by TYK2

  2014cites this paper
• Structural basis of recognition of interferon-α receptor by tyrosine kinase 2

  2014cites this paper
• Functional Characterization of the Kinase and Pseudokinase Domains in the Janus Tyrosine Kinase (JAK) 2

  2014cites this paper
• JAK2 mutation and treatment of JAK2 inhibitors in Philadelphia chromosome-negative myeloproliferative neoplasms

  2014cites this paper
• Combined Immunodeficiency Evolving into Predominant CD4+ Lymphopenia Caused by Somatic Chimerism in JAK3

  2014cites this paper
• Co-immunoprecipitation protocol to investigate cytokine receptor-associated proteins, e.g., Janus kinases or other associated signaling proteins.

  2013cites this paper
• Janus kinase inhibitors in autoimmune diseases

  2013cites this paper
• The role of activating mutations in the ferm domain of Janus kinase 3 in the development of adult t-cell leukemia/lymphoma

  2013cites this paper
• Cytokine Receptors Region of Janus Kinase 1 Interact with Two Distinct Domains Within the N-Terminal

  2013cites this paper
• analyses of 10 patients and outcomes of stem cell transplantation Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular

  2013cites this paper
• MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells

  2012cites this paper
• Regulation of JAKs: Insights gleaned from the functional protein domains

  2012cites this paper
• Impact of interferon β and interferon stimulated gene induction on Bunyamwera virus replication

  2012cites this paper
• Janus kinase 3: the controller and the controlled.

  2012cites this paper
• leukemia/lymphoma FERM domain mutations induce gain of function in JAK3 in adult T-cell

  2011cites this paper
• The use of structural biology in Janus kinase targeted drug discovery.

  2011cites this paper
• FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma.

  2011cites this paper
• Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinases

  2010cites this paper
• A receptor-independent, cell-based JAK activation assay for screening for JAK3-specific inhibitors.

  2010cites this paper
• Erythropoiesis Is Expressed During jak2a Divergent Embryonic Expression Patterns: Only Homologs Is Accompanied by JAK2 Gene Duplication of Zebrafish

  2010cites this paper
• Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection.

  2010cites this paper
• Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies.

  2010cites this paper
• PTP1B regulation of the transcription factor Stat5 in breast cancer

  2009cites this paper
• RNA virus modulation of IFN, PI3K and apoptosis

  2009cites this paper
• T Lymphocytes + Apoptosis in Tumor-Reactive Activated CD 8 Regulatory T Cell Expansion and Induce Tumor-Derived Microvesicles Promote

  2009cites this paper
• Janus kinases in immune cell signaling

  2009cites this paper
• Downregulation of Janus kinase 3 expression by small interfering RNA in rat composite tissue allotransplantation.

  2009cites this paper
• Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes1

  2009cites this paper
• Myeloproliferative disorders.

  2008cites this paper
• Therapeutic targeting of Janus kinases

  2008cites this paper
• Investigation of the role of haematopoietic cell kinase in normal and leukaemic haematopoiesis

  2008cites this paper
• Type I IL-4Rs Selectively Activate IRS-2 to Induce Target Gene Expression in Macrophages

  2008cites this paper
• Jak2 FERM Domain Interaction with the Erythropoietin Receptor Regulates Jak2 Kinase Activity

  2007cites this paper
• Jak2 tyrosine kinase

  2007cites this paper
• Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.

  2007cites this paper
• JAK1 N‐terminus binds to conserved box 1 and box 2 motifs of cytokine receptor common β subunit but signal activation requires JAK1 C‐terminus

  2006cites this paper
• A functional Jak2 tyrosine kinase domain is essential for mouse development.

  2006cites this paper
• Jak2 tyrosine kinase

  2006cites this paper
• Jaks and cytokine receptors--an intimate relationship.

  2006cites this paper
• Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2

  2006cites this paper
• Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs

  2005cites this paper
• Tolerogenic Dendritic Cells: Immunomodulation of Monocyte-Derived Dendritic Cells with n-Butyrate, NFκB Inhibitor PDTC and JAK3 Inhibitor WHI-P-154

  2005cites this paper
• Unique advantage of Janus kinase 3 as a target for selective and nontoxic immunosupression

  2005cites this paper
• Caractérisation du rôle de la voie Jak/STAT dans la réponse mitogénique des récepteurs couplés aux protéines G

  2005cites this paper
• CXCL12 Signaling Is Independent of Jak2 and Jak3*

  2005cites this paper
• Inhibition of the antigen‐induced activation of rodent mast cells by putative Janus kinase 3 inhibitors WHI‐P131 and WHI‐P154 in a Janus kinase 3‐independent manner

  2005cites this paper
• Jak3-Independent Trafficking of the Common γ Chain Receptor Subunit: Chaperone Function of Jaks Revisited

  2004cites this paper
• Jak3-Independent Trafficking of the Common (cid:2) Chain Receptor Subunit: Chaperone Function of Jaks Revisited

  2004cites this paper
• Is JAK3 a new drug target for immunomodulation-based therapies?

  2004cites this paper
• The role of Janus Kinase 3 in CD4+ T Cell Homeostasis and Function: A Dissertation

  2004cites this paper
• Study of mechanisms of activation of the interleukin-5 and leptin receptor

  2004cites this paper
• Severe combined immune deficiencies due to defects of the common γ chain-JAK3 signaling pathway

  2004cites this paper
• A True Jak of All Trades

  2004cites this paper
• Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.

  2004cites this paper
• Cytokines and immunodeficiency diseases: critical roles of the γc‐dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways

  2004cites this paper
• Janus kinase 3: a novel target for selective transplant immunosupression

  2004cites this paper
• Jak3 and the pathogenesis of severe combined immunodeficiency.

  2004cites this paper
• Jak2 TYROSINE KINASE: NEW INSIGHTS REGARDING STRUCTURE, FUNCTION, AND PHARMACOLOGY

  2004influential citation
• The Janus Kinase Protein Family

  2003cites this paper
• Suppression of early T-cell–receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154

  2003cites this paper
• Non-receptor protein tyrosine kinases.

  2003cites this paper
• Characterization and Analysis of the Proximal Janus Kinase 3 Promoter1

  2003cites this paper
• L'hormone de croissance : une cytokine

  2003influential citation
• A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity

  2003cites this paper
• Signaling through the Jak-Stat pathway: Regulation of tyrosine kinase activity

  2002cites this paper
• Two Distinct Domains Within the N-Terminal Region of Janus Kinase 1 Interact with Cytokine Receptors1

  2002cites this paper
• Clinical Observations, Interventions, and Therapeutic Trials

  2002cites this paper
• VIRUSES AND THE TYPE I INTERFERON ANTIVIRAL SYSTEM: INDUCTION AND EVASION

  2002cites this paper
• Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7.

  2002cites this paper
• JAKs, STATs and Src kinases in hematopoiesis

  2002cites this paper
• Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.

  2002cites this paper
• Orientational Constraints of the gp130 Intracellular Juxtamembrane Domain for Signaling*

  2002cites this paper
• Signaling through the JAK/STAT pathway, recent advances and future challenges.

  2002cites this paper
• Differential regulation of CD3- and CD28-induced IL-2 and IFN-gamma production by a novel tyrosine kinase inhibitor XR774 from Cladosporium cf. cladosporioides.

  2001cites this paper